BS ReporterHyderabad, 3 October: The dwindling anti-retroviral(ARV) contribution to the overall revenues of Aurobindo Pharma is likely to see... ...http://www.business-standard.com/article/companies/aurobindo-s-new-anti-hiv-drug-may-reverse-fall-in-anti-retroviral-business-117100300857_1.html
The firm is one of the leading manufacturers of APIs for anti-retroviral (ARV), Hepatitis C, and Oncology ...http://www.business-standard.com/article/companies/laurus-labs-gets-usfda-nod-for-visakhapatnam-unit-117091501017_1.html
Aurobindo Pharma's performance for the June quarter missed expectations. US sales (nearly half of revenue) declined by half a per cent year-on-year... ...http://www.business-standard.com/article/companies/aurobindo-s-q1-a-miss-but-much-better-than-peers-117081001190_1.html
Mylan Pharmaceuticals Private Limited, a subsidiary of Mylan N.V., a leading global pharmaceutical company, has received marketing authorisation... ...http://www.prokerala.com/news/articles/a763364.html
A vaginal ring that contains an experimental antiretroviral (ARV) drug, previously found to provide protection against HIV infection in women, has... ...http://www.prokerala.com/news/articles/a759490.html
ARV Holidays PVT. LTD. is a prominent...
ARV New Town, a launched Residential...
b day april 28